Management of women with atypical ductal hyperplasia (ADH) diagnosed on needle core biopsy of a screen-detected breast lesion

Scroll down to access downloads and media.

The BreastScreen Australian (BSA) Clinical Advice researched treatment guidelines for managing women with atypical lesions as part of the BreastScreen Australia screening program. This advice outlines their recommendation.

Management of women with atypical ductal hyperplasia

Management of women with atypical ductal hyperplasia (ADH) diagnosed on needle core biopsy of a screen-detected breast lesion [PDF - 211 KB] - 1 page

Management of women with atypical ductal hyperplasia (ADH) diagnosed on needle core biopsy of a screen-detected breast lesion [Word - 140 KB] - 1 page

About this resource

Publication date:

28 February 2018

Publication type:

Guideline

Language:

English

Part of a collection:

BreastScreen Australia Clinical Advice

Tags:

Preventive health
Cancer
BreastScreen Australia Program

Sub menu

Management of women with atypical ductal hyperplasia (ADH) diagnosed on needle core biopsy of a screen-detected breast lesion

Management of women with atypical ductal hyperplasia

About this resource

Help us improve health.gov.au